Fulminant Hepatitis following COVID-19 Vaccination: A case report
- Mohammad Barary,
- Athena Sharifi-Razavi,
- Nasser Rakhshani,
- Terence Sio,
- Soheil Ebrahimpour,
- Mana Baziboroun
Mohammad Barary
Babol University of Medical Science
Corresponding Author:m.barary@mubabol.ac.ir
Author ProfileAthena Sharifi-Razavi
Mazandaran University of Medical Sciences
Author ProfileAbstract
The side effects of COVID-19 vaccination were mostly self-restricted
local reactions that quickly resolved. Nevertheless, rare autoimmune
hepatitis cases have been reported in some vaccinated individuals. This
article presents a young man who developed fulminant hepatitis a few
days after vaccination with the first dose of the AstraZeneca COVID-19
vaccine.08 Jan 2022Submitted to Clinical Case Reports 16 Feb 2022Submission Checks Completed
16 Feb 2022Assigned to Editor
24 Feb 2022Reviewer(s) Assigned
06 May 2022Review(s) Completed, Editorial Evaluation Pending
06 May 2022Editorial Decision: Revise Minor
15 May 20221st Revision Received
16 May 2022Submission Checks Completed
16 May 2022Assigned to Editor
16 May 2022Review(s) Completed, Editorial Evaluation Pending
19 May 2022Reviewer(s) Assigned
02 Jul 2022Editorial Decision: Accept